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Abstract
Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here,
we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with
a focus on regions where aberrations in dopaminergic function have previously been associated with psychotic symptoms
and a genetic liability to schizophrenia. Scores on divergent thinking tests (Inventiveness battery, Berliner Intelligenz
Struktur Test) were correlated with regional D2 receptor densities, as measured by Positron Emission Tomography, and the
radioligands [
11C]raclopride and [
11C]FLB 457. The results show a negative correlation between divergent thinking scores
and D2 density in the thalamus, also when controlling for age and general cognitive ability. Hence, the results demonstrate
that the D2 receptor system, and specifically thalamic function, is important for creative performance, and may be one
crucial link between creativity and psychopathology. We suggest that decreased D2 receptor densities in the thalamus
lower thalamic gating thresholds, thus increasing thalamocortical information flow. In healthy individuals, who do not suffer
from the detrimental effects of psychiatric disease, this may increase performance on divergent thinking tests. In
combination with the cognitive functions of higher order cortical networks, this could constitute a basis for the generative
and selective processes that underlie real life creativity.
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Introduction
Creativity can be generically defined as the ability to produce
work that is at the same time novel and meaningful, as opposed to
trivial or bizarre [1]. A main psychometric approach to measuring
individual differences in creativity is represented by divergent
thinking tests. These tests typically involve generating a multitude
of novel and meaningful responses to open-ended questions. For
instance, in the classical Guilford’s alternate uses test [2],
participants are instructed to propose different uses for certain
artifacts, such as a brick, within a limited time.
Scores on divergent thinking tests show positive correlations
with involvement in real-life creative activities, self-rated creativity
[3], as well as objective measures of creative achievement, even
when controlling for IQ [4]. They are also correlated with several
personality traits, such as Openness to Experience, common to
individuals with documented creative capacity [3]. In the standard
three-stratum model of human cognitive abilities, the Cattell-
Horn-Carroll-framework [5], the main ability captured by
divergent thinking tests corresponds to the second-order factor
‘‘long-term storage and retrieval’’ (Glr), which captures individual
differences in fluent retrieval of information through association.
This factor, thus, predicts creative achievement over and above
fluid reasoning (Gf) and crystallized ability (Gc), i.e. beyond
traditional measures of ‘‘intelligence’’ and ‘‘knowledge’’.
Divergent thinking is influenced by dopaminergic function.
Reuter [6] found a correlation between divergent thinking (the
Inventiveness battery of the Berliner Intelligenz Struktur Test) and
polymorphisms of the dopamine D2 receptor gene–DRD2 TAQ
IA. Higher creativity scores were observed in carriers of the A1
allele. This polymorphism is unrelated to general intelligence
[7,8], which suggests that it is more specifically related to Glr. This
finding is in line with functional imaging research showing the D2
system to be involved in attentional set shifting and response
flexibility, which are important components of divergent thinking
[9]. Furthermore, the finding indicates that divergent thinking is
related to regional differences in D2 densities, since the DRD2
TAQ IA polymorphism has been shown to modulate D2 binding
potential (D2BP) in both striatal [10] and extrastriatal regions [11].
A clue to where to expect regional D2 density differences related
to divergent thinking comes from the link between creativity and
psychopathology: In healthy individuals, various creativity-related
measures, including divergent thinking, have been associated with
the personality traits psychoticism and schizotypy, as well as
genetic liability for schizophrenia spectrum and bipolar disorders
[12–21]. Notably, the networks relevant to divergent thinking, i.e.
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tical loops [22,23], overlap to a great extent with regions and
networks affected in schizophrenia and bipolar disorder. Further-
more, dopamine is known to influence processing in these
networks and alterations in dopaminergic function and activity
of D2 receptors have been linked to both positive and negative
psychotic symptoms (e.g. [24–27]).
Two regions appear to be of particular interest in this context:
the thalamus and the striatum. Several studies have shown
thalamic D2BP to be reduced in drug-naı ¨ve schizophrenia patients
[26–31]. Moreover, D2BP in subregions of the thalamus was
found to be negatively related to total symptoms, general
symptoms, positive symptoms, hostility and suspiciousness
[28,31] as well as grandiosity [26]. The direction of this correlation
would match with the association between DRD2 TAQ AI and
divergent thinking [6]. A metaanalysis by Weinberger and
Laurelle [27] found a significant elevation of striatal D2 receptors
in untreated patients with schizophrenia. A later study on twins
discordant for schizophrenia shows that this upregulation might be
related to a genetic risk for schizophrenia [32]. Two studies have
found positive correlations between ventral striatal D2BP and the
specific symptoms Disorientation [26] and Hallucinations [29].
Although the density of D2 receptors in cortical regions is very
low [33] and thus difficult to estimate using PET due to low signal-
to noise ratio, a few studies have found correlations between
positive symptoms in schizophrenia and D2BP in cortical regions
[29,34,35]. However, the results across studies are not consistent
and more experimental data are required in order to determine
their significance to cognition [9]. Hence, it is difficult to state a
clear hypothesis about the relation between cortical D2 receptor
density and divergent thinking.
Based on these findings, our main hypotheses were that higher
scores on divergent thinking would be associated with lower D2BP
in the thalamus and/or higher D2BP in the striatum. Since the
frontal cortex has been implicated in creative ability from other
lines of research (see e.g. [22]), this region was also included in the
analysis. For exploratory purposes, we performed an additional
analysis of striatal functional subregions.
Results
Descriptive statistics of all variables of interest are summarized
in Table 1. Table 2 shows partial correlations between regional
D2BP and divergent thinking controlling for age. These
correlations are also illustrated in Figure 1. There was a significant
negative correlation between D2BP and divergent thinking in the
thalamus (Fig. 1A; r=2.64, p=.013; Bonferroni corrected
a=.017), confirming our hypothesis with regard to this region.
This correlation remained significant when simultaneously
controlling for age and Raven scores. There was no significant
correlation between divergent thinking and D2BP in the striatum
(Fig. 1B; r=.10, p=.37) nor in the frontal cortex (Fig. 1C;
r=2.23, p=.46), or in any striatal subregion (associative striatum:
r=.05, p=.44; ventral striatum: r=.35, p=.13; sensorimotor
striatum: r=.07, p=.37). Raven scores were not associated with
any other measure.
Discussion
The main finding in the present study is a negative correlation
between divergent thinking and D2BP in the thalamus, thus
confirming our hypothesis for this region. There was no significant
correlation between divergent thinking and D2BP in the striatum
or in the frontal cortex. Furthermore, there were no relations
between Raven scores and BIS scores, or between Raven scores
and D2BP, which is in line with previous findings showing that
divergent thinking is essentially separate from measures of
intelligence.
Two methodological issues should be considered. Firstly, the
time between the PET-examination and the administration of the
divergent thinking test was quite extended (approximately eighteen
months). However, in thalamus - where significant results were
found - the age effect on D2BP is less pronounced: In a sample of
35 participants, age range 16–50, Talvik [26] found a 6% decline
in the right thalamus per decade, and no significant decrease at all
in the left thalamus. Secondly, since D2BP is a function of both
receptor density and apparent affinity, these parameters cannot be
dissociated based on a single PET measurement [36]. Among the
factors influencing apparent affinity, endogenous dopamine levels
have been shown to affect [
11C]FLB 457 binding [37,38,39].
However, other studies have been negative [40,41] and using
scatchard approaches where Kd and Bmax can be separated is has
been shown that Bmax accounts for most of the variance in BP
[42]. This suggests that the low D2BP measurements in individuals
with high creativity scores demonstrated in the present study are
related primarily to a reduced density of dopamine D2 receptors,
rather than an increased level of endogenous dopamine.
Divergent thinking and thalamic D2BP
In the past, several different measures of divergent test
performance have been used, e.g. Fluency–the number of valid
responses; Originality–how frequent the participant’s responses
Table 1. Mean values, minimum, maximum and standard
deviations of all variables of interest.
Measure Age BIS ZF AM TN Raven Thalamus Striatum FC
M 59 296 103 98 95 39 2.60 2.63 0.40
Minimum 41 269 83 72 80 29 1.86 2.27 0.21
Maximum 65 350 119 117 114 52 3.28 2.99 0.65
SD 8 23 13 15 10 6 0.50 0.18 0.15
Age = Participant age; BIS = Berliner Intelligenz Struktur Test scores; ZF = BIS
subtest figural fluency; AM = BIS subtest verbal fluency; TN = BIS subtest
numerical fluency; Raven = Raven’s Standard Progressive Matrices Plus scores.
Thalamus = Dopamine D2 receptor binding potential (D2BP) in the thalamus;
Striatum = D2BP in the striatum; FC = D2BP in the frontal cortex.
doi:10.1371/journal.pone.0010670.t001
Table 2. Partial correlations between regional D2 receptor
binding potential, divergent thinking and intelligence,
controlling for age.
Measure Raven BIS
Thalamus .27 P=.40 2.64 P=.013*
a
Striatum .39 P=.21 .01 P=.37
a
FC .31 P=.32 2.23 P=.46
*Significant at p#0.017, corrected for multiple comparisons (n=3) using an
a=0.05.
aOne-tailed p-value (direction of correlation according to hypothesis). Other
values are two-tailed.
Raven = Raven’s Standard Progressive Matrices Plus scores; BIS = Berliner
Intelligenz Struktur Test scores; Thalamus = Dopamine D2 receptor binding
potential (D2BP) in the thalamus; Striatum = D2BP in the striatum; FC = D2BP
in the frontal cortex.
doi:10.1371/journal.pone.0010670.t002
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number of semantic categories produced; Switching–the number
of shifts between semantic categories; and Elaboration–how
extensive each response is (if the task involves producing more
than single words). Importantly however, all these measures have
been found highly intercorrelated: Someone who has high fluency
is also more likely to show more flexibility of thought and provide
more elaborate and uncommon solutions. One simple explanation
to this was given by Campbell [43] who reformulated an original
idea by Guilford [44] into a theory of ‘‘blind variation and
selective attention’’. In brief, if idea generation is based on a more
or less random process of free association, and you are able to
come up with many ideas, the probability for being flexible and
original is consequently increased.
Based on the current findings, we suggest that a lower D2BP in
the thalamus may be one factor that facilitates performance on
divergent thinking tasks. The thalamus contains the highest levels
of dopamine D2 receptors out of all extrastriatal brain regions
[33,45]. Decreased D2BP in the thalamus has been suggested,
firstly, to lower thalamic gating thresholds, resulting in decreased
filtering and autoregulation of information flow [31] and,
secondly, to increase excitation of cortical regions through
decreased inhibition of prefrontal pyramidal neurons [46,47,48].
The decreased prefrontal signal-to-noise ratio may place networks
of cortical neurons in a more labile state, allowing them to more
easily switch between representations and process multiple stimuli
across a wider association range [49]. This state, which we
hereforth will refer to as the ‘‘creative bias’’, could benefit
performance on tasks that involve continuous generation and (re-
)combination of mental representations and switching between
mind-sets. The creative bias could also explain why the different
measures of divergent task performance correlate: A decreased
signal-to-noise ratio in thalamus would decrease information
gating and possibly increase fluency; decreased signal-to-noise
ratio in cortical regions should better enable flexibility and
switching between representations; similarly, the associative range
should be widened and selectivity should be decreased which
might spur originality and elaboration.
Divergent thinking and psychopathology
Besides carrying benefits related to fluency and switching, the
decreased signal-to-noise ratio associated with the creative bias
should be disadvantageous in relation to tasks that require high
levels of selective attention. Some support for this prediction can
be taken from Dorfman [50] who showed that the greater a
person’s divergent thinking scores, the slower his or her reaction
times were on a negative priming task requiring the inhibition of
interfering information. Furthermore, the creative bias may also
bring a risk of excessive excitatory signals from the thalamus
overwhelming cortical neurotransmission, with ensuing cognitive
disorganization and positive symptoms [30]. It is thus tempting to
suggest that dopaminergic modulation of neurotransmission
mediated through dopamine D2-receptors could be one of the
mechanisms which associate creativity with positive psychotic
symptoms. Interestingly, positive symptoms are not necessarily
related to problems in executive function, at least not to the same
extent as negative symptoms [51], which indicates that in the
creative individual ‘‘blind variation’’ might be affected without a
concomitant decline in ‘‘selective retention’’. It can be speculated
that aberrant thalamic function may promote unusual associa-
tions, as well as improved performance on divergent thinking tests
in healthy individuals, in the absence of the detrimental effects
typically associated with psychiatric disorders. In other words,
thinking outside the box might be facilitated by having a
somewhat less intact box.
Materials and Methods
Ethics statement
All participants gave verbal and written informed consent and
the study was approved by the Ethics and Radiation Safety
committees of Karolinska Institutet (Dnr. 2007/704-31/4, 02-431,
2007/1611-32).
Participants
The participants in the present study had previously served as
control subjects in a clinical study [52]. Fourteen participants (6
male, 8 female) with at least nine years of basic education were
included in the study (age: 41–65, M=5668 years). The
participants had no history of neurological or psychiatric illness,
as determined by clinical interview, MRI examination, blood and
urine tests, and ECG. None of the subjects were nicotine users,
and the use of caffeine or alcohol was not allowed during the days
of PET examinations. All women were menopausal. One
participant was excluded from analysis because of an extremely
low Raven score, giving a total of thirteen participants.
Figure 1. Correlations between divergent thinking scores and dopamine D2 binding potential. (A) Correlation between thalamic D2
binding potential (D2BP) and divergent thinking (BIS score). (B) Correlation between D2BP and BIS score in the striatum. (C) Correlation between
D2BP and BIS score in the frontal cortex.
doi:10.1371/journal.pone.0010670.g001
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The psychological tests were administered individually. The
personality questionnaires were administered in connection with
the PET-experiments. Divergent thinking and general cognitive
ability was assessed approximately eighteen months after the
original PET-examination.
Divergent thinking. Divergent thinking was assessed using
three timed subtests from the ‘‘inventiveness’’ test battery of the
‘‘Berliner Intelligenz Struktur Test’’ (BIS) [53]. The tests measured
performance within the figural, verbal, and numeric domains and
were chosen based on their having the highest factor loadings on the
total inventiveness-score. In the figural test, a simple line drawing
should be completed in various ways in order to create pictures of as
many possible real objects as possible. In the verbal test, the
participant was instructed to produce as many alternate uses for a
given object as possible. In the numeric test the participant had to
generate as many logical number sequences as possible, while trying
to vary the rule of construction. Raw scores from each subtest were
transformed into Z scores [53], which were subsequently summed
and used as a composite measure of divergent thinking.
General cognitive ability. General cognitive ability was
assessed using the Raven’s Standard Progressive Matrices Plus
(Raven) [54], a widely used test that mainly reflects psychometric
general intelligence (g) [55]. The test was administered without
time limit.
MR and PET experimental procedure
Magnetic resonance (MR) and head fixation system. T1
weighted MR-images were acquired using a 1.5 T GE Signa
system (Milwaukee, WI) To allow for the same head position in all
measurements and to minimize head movement, a plaster helmet
was made for each participant individually and used during both
MRI and PET examinations [56].
Positron emission tomography (PET) examinations. PET
studies were performed on an ECAT Exact HR system (CTI Siemens,
Knoxville, TN) [
11C]raclopride and [
11C]FLB 457 were prepared
from [
11C]methyl triflate as described previously [57,58]. The
radioligands were given intravenously as a rapid bolus and the
cannula was flushed with saline. Radioactivity in the brain was
measured during 51 min for [
11C]raclopride and 87 min for [
11C]
FLB 457,
Image processing and analysis. The MR-images were
realigned to the AC–PC plane using the SPM2 software and PET
images were coregistered to the MR image using the normalized
mutual information method implemented in SPM2 (Wellcome
Department of Imaging Neuroscience, London, UK). For
determination of regional radioligand binding, regions of interest
(ROIs) were manually delineated on each individual MR-image
using the Human Brain Atlas software.
In the present study, the selection of ROIs was limited to the
thalamus and frontal cortex for [
11C]FLB 457 examinations,
and to the striatum for [
11C]raclopride examinations. In an
extended anatomical analysis of the striatum, ROIs for striatal
subregions were defined according to a method described in the
literature [59,60] in which striatum is divided into ventral,
associative and sensorimotor subregions based on the differen-
tial connectivity of the striatum [61]. ROIs for the thalamus
were defined using a modified version of a procedure described
previously [31,62,63]. Finally, a ROI for cerebellum was drawn
below the petrosal bone using five slices, corresponding to a
thickness of 10 mm. For an example of ROI delineation, see
Figure 2.
The ROIs were transferred to the series of PET images to
generate time–activity curves (procedure described elsewhere
[52]). D2 receptor binding potential (BP) values were calculated
using the simplified reference tissue model with the cerebellum as
reference region. In this context, BP refers to BPND, which
represents the ratio at equilibrium of specifically bound radioli-
gand to that of nondisplaceable radioligand in tissue [64]. The
SRTM has previously been validated for both [
11C]raclopride and
[
11C]FLB 457 [65] and [66].
Data analysis
Data was analyzed using Statistica 8.0 (StatSoft). A partial
correlation between regional thalamic D2BP, striatal D2BP,
intelligence and divergent thinking was then performed, keeping
participant age constant. For the thalamus and the striatum,
one-tailed significance tests were used, since we predicted
negative and positive directions of the correlations, respectively.
Significance levels were Bonferroni corrected (n=3; thalamus/
striatum/frontal cortex). Striatal subregions were analyzed
separately in an extended analysis, also using one-tailed
significance tests.
Author Contributions
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Figure 2. Regions of interest (ROI). (A) Sagittal image of regional radioactivity after intravenous injection of [
11C]FLB 457 in one subject. Thalamic
ROI. (B) Coronal image of regional radioactivity after intravenous injection of [
11C]raclopride. Striatal ROI.
doi:10.1371/journal.pone.0010670.g002
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